Octreotide Acetate丨CAS 83150-76-9

Octreotide Acetate丨CAS 83150-76-9
Product Introduction:
Catalog No.: SS130646
CAS No.: 83150-76-9
Assay: 96.0%~102.0%
Product Name: Octreotide acetate
Molecular Formula: C49H66N10O10S2.2(C2H4O2)
Molecular Weight: 1139.35
Synonym(s): Octreotide
Send Inquiry
Technical Parameters
Description

Hangzhou Leap Chem Co., Ltd. is one of the most professional manufacturers and suppliers of octreotide acetate丨cas 83150-76-9 in China. Welcome to wholesale bulk high quality chemical products at competitive price from our factory. If you have any enquiry about custom service, please feel free to email us.

 

Specifications

 

Appearance: White or off-white freeze-dried powder or loose lump substance
Assay: 96.0% ~ 102.0%
Solubility: Freely soluble in water and glacial acetic acid, insoluble in ether
Color reaction: Should appear positive reaction
Identification: Retention time of main peak of test sample should be consistent with reference substance
Specific rotation: -66.0° ~ -76.0°
pH: 5.0 ~ 7.0
Water: 10.0% max.
Acetic acid: 5.0% ~ 12.0%
Related substance:
Single impurity: 1.0% max.
Total impurities: 2.0% max.
TAMC: 100 CFU/g max.
TYMC: 10 CFU/g max.
Bile-Tolerant Gram-Negative Bacteria: Not detectable
Pseudomonas aeruginosa: Not detectable
Staphylococcus aureus: Not detectable
Bacterial endotoxin: 100 EU/mg max.
Amino acids:
Cys: 1.7 ~ 2.3
Thr: 0.8 ~ 1.2
Phe: 1.8 ~ 2.2
Lys: 0.9 ~ 1.1
Threoninol: Should be detected

 

Transport Information

 

Parameter

Specification

UN Number

 

Class

 

Packing Group

 

H.S. Code

2933990099306

Stability & Reactivity

The product is chemically stable under standard ambient conditions.

Storage

Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: -20 °C

Condition to Avoid

 

Package

 

 

Manufacturing Information

 

Parameter

Specification

Capacity

 

Frequency

 

Main Export Countries

 

Capacity/Batch

 

Experience

Production since 2015

Stock

 

 

 

 

Applications

 

1. Treatment of Acromegaly

Used to suppress excessive growth hormone (GH) secretion in patients with acromegaly.

Helps normalize insulin-like growth factor 1 (IGF-1) levels.

Controls symptoms such as enlarged hands, feet, and facial features.

2. Management of Neuroendocrine Tumors

Controls hormone-related symptoms (e.g., flushing, diarrhea) in patients with carcinoid tumors and vasoactive intestinal peptide tumors (VIPomas).

Inhibits tumor hormone secretion and may slow tumor growth.

3. Control of Gastrointestinal Bleeding

Used off-label for managing bleeding esophageal varices due to its vasoconstrictive properties.

4. Other Endocrine Disorders

Sometimes used to treat thyrotropin-secreting pituitary adenomas and other hormone-secreting tumors.

 

Benefits

 

Potent Hormone Inhibitor: Effectively reduces secretion of GH, insulin, glucagon, and other hormones.

Prolonged Duration: Longer half-life compared to native somatostatin allows less frequent dosing.

Symptom Control: Improves quality of life by alleviating symptoms caused by hormone hypersecretion.

Tumor Growth Inhibition: Exhibits antiproliferative effects on certain neuroendocrine tumors.

Multiple Administration Routes: Available as subcutaneous injection and long-acting depot formulations.

 

Conclusion

 

Octreotide Acetate (CAS 83150-76-9) is a clinically valuable somatostatin analog used primarily to treat acromegaly and neuroendocrine tumors by inhibiting hormone secretion and controlling symptoms. Its longer half-life and potent activity make it an essential drug in endocrinology and oncology, offering symptom relief and disease management in various hormone-related disorders.

 

 

Send Inquiry
Beyond Your Expectation
From Science to Life with LEAPChem
contact us